to evaluate the long-term effects of reperfusion with tissue plasminogen activator ( t-pa ) and an aggressive strategy of revascularization with angioplasty and coronary artery bypass grafting , we obtained 1-year follow-up results from 386 consecutive patients enrolled in the thrombolysis and angioplasty in myocardial infarction ( tami i ) trial .
C0032143
tissue plasminogen
C0027051
myocardial infarction